Advertisement
BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. (BMRN) Stock Overview

Explore BioMarin Pharmaceutical Inc.’s financial performance, market position, analyst ratings, and future outlook.

BMRN●NASDAQ
HealthcareBiotechnology
$56.47
$1.81(3.31%)
U.S. Market opens in 16h 7m
Advertisement

BioMarin Pharmaceutical Inc. (BMRN)

Meyka AI Score

Z

Key Financials

Market Cap10.9B
P/E Ratio39.12
EPS (TTM)$1.39
ROE0.04%
Fundamental Analysis

AI Price Forecasts

1 Month$50.91
3 Months$59.58
1 Year Target$39.73

BMRN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioMarin Pharmaceutical Inc. (BMRN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.03, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $39.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 39.12 and a market capitalization of 10.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.31%
5-Day Change
5.55%
1-Month Change
1.82%
3-Month Change
-6.55%
6-Month Change
4.92%
Year-to-Date (YTD) Change
-4.98%
1-Year Change
0.64%
3-Year Change
-38.44%
5-Year Change
-27.50%
All-Time (Max) Change
330.08%

Contact Information

https://www.biomarin.com
415 506 6700
770 Lindaro Street, San Rafael, CA, 94901

Company Facts

3,040 Employees
IPO DateJul 26, 1999
CountryUS
Actively Trading

Frequently Asked Questions